http://www.healthpointcapital.com/research/ en Copyright 2010 HealthpointCapital LLC Thu, 11 Mar 2010 06:13:00 -0500 http://www.movabletype.org/?v=3.35 http://blogs.law.harvard.edu/tech/rss The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant]]> http://www.healthpointcapital.com/research/2010/03/11/musculoskeletal_news_roundup_aaos_edition/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/11/musculoskeletal_news_roundup_aaos_edition/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Musculoskeletal News Roundup Thu, 11 Mar 2010 06:13:00 -0500 With healthcare reform projected to cost $950 billion, the pharma, device and hospital industries have generally consented to help fund the changes - in the device industry's case, to the tune of $20 billion over the next decade, which will be realized through an excise tax proposed to be implemented in 2011. AdvaMed is pushing on behalf of the industry to lock in that $20 billion as a cap, reports Reuters. ]]> http://www.healthpointcapital.com/research/2010/03/10/device_industry_seeks_cap_on_healthcare_reform_fees/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/10/device_industry_seeks_cap_on_healthcare_reform_fees/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Legislation Wed, 10 Mar 2010 14:21:24 -0500 Wear debris and surgical technique are at the center of a New York Times article on metal-on-metal total hip components, with the paper suggesting that metal-on-metal correlates to poorer outcomes and higher revision rates. The article cites a metal-on-metal revision rate of 1-3%, with women affected more frequently than men.]]> http://www.healthpointcapital.com/research/2010/03/08/nyt_challenges_metalonmetal_hips/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/08/nyt_challenges_metalonmetal_hips/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Hip Mon, 08 Mar 2010 07:56:10 -0500 Corin, Osteotech and Integra report 4Q . . . Baxter to acquire ApaTech for up to $330.0 million . . . Intrinsic Therapeutics closes on $18.0 million of a $20.0 million round . . . FDA schedules Orthopaedic and Rehabilitation Devices Panel meeting for Menaflex . . . Aetna and United Healthcare reverse prior policies and announce that they will cover NuVasive's XLIF . . . Congress delays Medicare pay cut]]> http://www.healthpointcapital.com/research/2010/03/04/musculoskeletal_news_roundup_4mar10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/04/musculoskeletal_news_roundup_4mar10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Musculoskeletal News Roundup Thu, 04 Mar 2010 08:05:45 -0500 collaborate on ways to bring innovative products to market sooner. Among other actions, the two agencies plan to create a Joint Leadership Council, which will focus on encouraging researchers to think about regulatory issues early in the technology development cycle. The council will also work to incorporate the latest scientific data into the FDA review process.]]> http://www.healthpointcapital.com/research/2010/03/03/nih_fda_introduce_fast_track_initiative_for_new_devices/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/03/nih_fda_introduce_fast_track_initiative_for_new_devices/?utm_source=rss&utm_medium=rss2&utm_campaign=feed FDA Wed, 03 Mar 2010 11:40:10 -0500 Aetna and United Healthcare both announced that they will cover XLIF, reversing non-coverage policies and allowing the procedure to shed its "investigational" status.]]> http://www.healthpointcapital.com/research/2010/03/02/aetna_uhc_reverse_payment_policies_for_xlif/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/02/aetna_uhc_reverse_payment_policies_for_xlif/?utm_source=rss&utm_medium=rss2&utm_campaign=feed NuVasive Tue, 02 Mar 2010 09:05:12 -0500 Baxter announced plans to acquire ApaTech for up to $330 million, with $240 million in cash up front (a 4x revenue multiple) and additional milestone payments of up to $90 million. ]]> http://www.healthpointcapital.com/research/2010/03/01/baxter_to_acquire_apatech_for_up_to_330_million/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/03/01/baxter_to_acquire_apatech_for_up_to_330_million/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Biologics Mon, 01 Mar 2010 10:28:55 -0500 Dentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions."]]> http://www.healthpointcapital.com/research/2010/02/26/dental_news_roundup_february_2010/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/26/dental_news_roundup_february_2010/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Dental Fri, 26 Feb 2010 14:53:56 -0500 Alphatec Spine reported 4Q:09 revenues of $36.6 million, an increase of 29% from the $28.4 million reported in 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. Asian revenues were $6.6 million, an increase of 38% from the $4.8 million reported for 4Q:08. European revenues in 4Q:09 were $1.7 million. ]]> http://www.healthpointcapital.com/research/2010/02/25/musculoskeletal_news_roundup_25feb10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/25/musculoskeletal_news_roundup_25feb10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Musculoskeletal News Roundup Thu, 25 Feb 2010 12:27:15 -0500 Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... http://www.healthpointcapital.com/research/2010/02/25/alphatec_spine_announces_expiration_of_hartscottrodino_review_period_for_acquisition_of_scientx_groupe_sas/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/25/alphatec_spine_announces_expiration_of_hartscottrodino_review_period_for_acquisition_of_scientx_groupe_sas/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Alphatec Spine, Inc. Thu, 25 Feb 2010 12:24:04 -0500 On Tuesday Nobel Biocare announced that it would expand its Preferred Partner Program to include Noritake Dental Supply. The company says the partnership "enables Nobel Biocare to offer superior end-to-end prosthetic solutions." Based in Nagoya, Japan, Noritake Dental specializes in... http://www.healthpointcapital.com/research/2010/02/25/nobel_biocare_announces_partnership_with_noritake/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/25/nobel_biocare_announces_partnership_with_noritake/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Nobel Biocare Thu, 25 Feb 2010 09:06:05 -0500 Despite the increased mobility associated with total knee replacement, a new study found that TKA patients actually gain more weight post-operatively than non-surgical controls. The study, published in Osteoarthritis and Cartilage, enrolled 106 TKA patients and 31 non-surgical controls. The... http://www.healthpointcapital.com/research/2010/02/23/tka_patients_gain_more_weight_postop_compared_to_healthy_controls/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/23/tka_patients_gain_more_weight_postop_compared_to_healthy_controls/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Clinical Studies Tue, 23 Feb 2010 13:31:33 -0500 This morning President Obama announced his plan for reforming healthcare. The proposal is similar to the legislation the Senate passed late last year, though it includes some concessions to the House, and the president describes it as "[bridging] the gap"... http://www.healthpointcapital.com/research/2010/02/22/president_obama_unveils_plan_for_healthcare_reform/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/22/president_obama_unveils_plan_for_healthcare_reform/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Legislation Mon, 22 Feb 2010 10:54:09 -0500 Yesterday the FDA hosted an all-day public hearing to gain feedback on its 510(k) process, looking specifically at issues of predicate devices, new technologies, submission volume and post-market surveillance. The event was webcast and opened to a packed house -... http://www.healthpointcapital.com/research/2010/02/19/industry_and_public_weigh_in_on_510k_process/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/19/industry_and_public_weigh_in_on_510k_process/?utm_source=rss&utm_medium=rss2&utm_campaign=feed FDA Fri, 19 Feb 2010 07:06:46 -0500 Earnings DJO reported 4Q:09 revenues of $257.2 million, up 5% over 4Q:08, with domestic rehab sales up 3% and domestic surgical implant sales up 8%. The company attributed the latter largely to "strong sales of our Reverse Shoulder Prosthesis." Net... http://www.healthpointcapital.com/research/2010/02/18/musculoskeletal_news_roundup_18feb10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed http://www.healthpointcapital.com/research/2010/02/18/musculoskeletal_news_roundup_18feb10/?utm_source=rss&utm_medium=rss2&utm_campaign=feed Musculoskeletal News Roundup Thu, 18 Feb 2010 06:51:29 -0500